SynBioBeta Speaker
Armaan Dhanda
Anomaly Bio
Co-Founder
Armaan is the co-founder of Anomaly Bio, a Singapore-based biotech company turning microbes into micro-factories to rebuild ingredient supply chains. Anomaly raised a US$2.6M pre-seed round led by SF-based Pebblebed Ventures, with participation from Akshay Kothari (Notion), Sean Hunt (Solugen), Eben Bayer (Ecovative), and Mithun Sacheti (CaratLane), amongst others. At SynBioBeta, Armaan will present on third-generation industrial biology companies — demand-led, capital-disciplined ventures that start with urgent problems inside large enterprises and scale only with validated offtake, drawing lessons from both the durable first generation and the ambitious but often over-extended second wave.Armaan is 23 and currently on leave from the National University of Singapore, where he studied Chemical Engineering as an S&T Scholar. He previously founded the Delhi Smart Protein Project, GFI's first Indian alt-protein chapter.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
09:11:40:50
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
